Twin Tree Management
MRTX

Twin Tree Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Twin Tree Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-106
Closed -$8K – 1627
2019
Q1 		$8K Buy
+106
New +$7.21K ﹤0.01% 1223

Other funds holding MRTX

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Twin Tree Management's MRTX Position: Q2 2019 in Review

Twin Tree Management sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q2 2019, closing a stake of 106 shares — an estimated $8K sold.

Twin Tree Management first reported a position in MRTX in Q1 2019 and held it in 1 quarter. The position peaked at $8K in Q1 2019. 172 funds tracked by Wall St. Rank hold MRTX as of Q2 2019.

  • Twin Tree Management reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Twin Tree Management sold 106 Mirati Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $8K.
  • Twin Tree Management first reported a position in Mirati Therapeutics, Inc. Common Stock in Q1 2019 and held it in 1 quarter.
  • Twin Tree Management's Mirati Therapeutics, Inc. Common Stock position peaked at $8K in Q1 2019.
  • 172 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Twin Tree Management's 13F filing for Q2 2019, filed 12 Aug 2019.